156 related articles for article (PubMed ID: 28870819)
41. From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis type 1: radiologic-pathologic correlation.
Levy AD; Patel N; Dow N; Abbott RM; Miettinen M; Sobin LH
Radiographics; 2005; 25(2):455-80. PubMed ID: 15798063
[TBL] [Abstract][Full Text] [Related]
42. Therapy for plexiform neurofibromas in children with neurofibromatosis 1: an overview.
Packer RJ; Rosser T
J Child Neurol; 2002 Aug; 17(8):638-41; discussion 646-51. PubMed ID: 12403563
[TBL] [Abstract][Full Text] [Related]
43. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
[TBL] [Abstract][Full Text] [Related]
45. [Anxiety disorders in type 1 neurofibromatosis: A case report].
Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
[TBL] [Abstract][Full Text] [Related]
46. [Plexiform neurofibroma in the gingiva].
Savaş H; Karabacakoğlu A; Karaköse S; Durmuş E
Tani Girisim Radyol; 2004 Mar; 10(1):39-43. PubMed ID: 15054702
[TBL] [Abstract][Full Text] [Related]
47. Plexiform neurofibroma of the small bowel infiltrated with metastatic adenocarcinoma.
Leslie A; Virjee JP; Moorghen M
Br J Radiol; 1999 Jun; 72(858):604-6. PubMed ID: 10560344
[TBL] [Abstract][Full Text] [Related]
48. Single-stage total endoscopic resection of a plexiform neurofibroma of the maxillary sinus in a child with type 1 neurofibromatosis.
Hachem RN; Bared A; Zeitouni J; Younis RT
Int J Pediatr Otorhinolaryngol; 2010 Apr; 74(4):426-9. PubMed ID: 20074816
[TBL] [Abstract][Full Text] [Related]
49. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of plexiform neurofibroma in neurofibromatosis type 1 in 18 family members of 3 generations: ultrasonography and magnetic resonance imaging a diagnostic supplement.
Sehgal VN; Sharma S; Oberai R
Int J Dermatol; 2009 Mar; 48(3):275-9. PubMed ID: 19261016
[TBL] [Abstract][Full Text] [Related]
51. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
[TBL] [Abstract][Full Text] [Related]
52. NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies.
Ponti G; Martorana D; Pellacani G; Ruini C; Loschi P; Baccarani A; De Santis G; Pollio A; Neri TM; Mandel VD; Maiorana A; Maccio L; Maccaferri M; Tomasi A
Anticancer Res; 2014 Jun; 34(6):3021-30. PubMed ID: 24922668
[TBL] [Abstract][Full Text] [Related]
53. [Managing children with neurofibromatosis type 1: what should we look for?].
Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
[TBL] [Abstract][Full Text] [Related]
54. Selumetinib: the first ever approved drug for neurofibromatosis-1 related inoperable plexiform neurofibroma.
Mukhopadhyay S; Maitra A; Choudhury S
Curr Med Res Opin; 2021 May; 37(5):789-794. PubMed ID: 33683166
[TBL] [Abstract][Full Text] [Related]
55. Unilateral gingival enlargement in patient with neurofibromatosis type I.
Asgary S; Aminzadeh N
N Y State Dent J; 2012 Nov; 78(6):50-3. PubMed ID: 23488326
[TBL] [Abstract][Full Text] [Related]
56. Incidence, types, and management of cancer in patients with neurofibromatosis.
Cohen BH; Rothner AD
Oncology (Williston Park); 1989 Sep; 3(9):23-30; discussion 34, 37-8. PubMed ID: 2518324
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous presentation of malignant peripheral nerve sheath tumor and moyamoya disease associated with neurofibromatosis type 1 in a child.
Yoo SY; Hwang SM; Lee MK; Jo DS; Hwang PH
Turk J Pediatr; 2015; 57(2):202-5. PubMed ID: 26690608
[TBL] [Abstract][Full Text] [Related]
58. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
[TBL] [Abstract][Full Text] [Related]
59. Neurofibromatosis type 1 and GIST: is there a correlation?
Valencia E; Saif MW
Anticancer Res; 2014 Oct; 34(10):5609-12. PubMed ID: 25275063
[TBL] [Abstract][Full Text] [Related]
60. Rhabdomyosarcoma arising from retroperitoneal teratoma in an infantile neurofibromatosis type 1 patient.
Aikawa A; Mizutani K; Futatsuya C; Kumagai M; Shioya A; Nakada S; Kurose N; Nojima T; Tsuzuki T; Yamada S
Pathol Int; 2019 Aug; 69(8):488-495. PubMed ID: 31328317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
